Evidence map›Paper›PMID 30981999›Full record

ArticleSexually transmitted infections2019

Impact of mass drug administration of azithromycin for trachoma elimination on prevalence and azithromycin resistance of genital

Mark Andrew Harrison, Emma Michele Harding-Esch, Michael Marks, Marcus James Pond, Robert Butcher, Anthony W Solomon, Liqing Zhou, NgeeKeong Tan, Achyuta V Nori, Henry Kako and 3 more

Open access · hybridAbstract read
In one paragraph

Article in Sexually transmitted infections, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.4field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Drug resistance ofFrontiers in cellular and infection microbiology · 2026
    Review
  3. Article
  4. Article
  5. Sexually transmitted infections · 2023
    Article
  6. Article
  7. Molecular Tools for TypingFrontiers in microbiology · 2022
    Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 2 countries.

Mark Andrew HarrisonApplied Diagnostic Research and Evaluation Unit, St George's, University of London, London, UK.ORCID 0000-0001-5586-0655
Emma Michele Harding-EschApplied Diagnostic Research and Evaluation Unit, St George's, University of London, London, UK.ORCID 0000-0002-1432-8109
Michael MarksClinical Research Department, London School of Hygiene and Tropical Medicine, London, UK.ORCID 0000-0002-7585-4743
Marcus James PondApplied Diagnostic Research and Evaluation Unit, St George's, University of London, London, UK.
Robert ButcherClinical Research Department, London School of Hygiene and Tropical Medicine, London, UK.
Anthony W SolomonClinical Research Department, London School of Hygiene and Tropical Medicine, London, UK.
Liqing ZhouApplied Diagnostic Research and Evaluation Unit, St George's, University of London, London, UK.
NgeeKeong TanSouthwest London Pathology, St George's University Hospitals NHS Foundation Trust, London, UK.
Achyuta V NoriApplied Diagnostic Research and Evaluation Unit, St George's, University of London, London, UK.
Henry KakoDepartment of STI and HIV Prevention, Ministry of Health and Medical Services, Honiara, Solomon Islands.
Oliver SokanaEye Health Department, Ministry of Health and Medical Services, Honiara, Solomon Islands.
David C W MabeyClinical Research Department, London School of Hygiene and Tropical Medicine, London, UK.
Syed Tariq SadiqApplied Diagnostic Research and Evaluation Unit, St George's, University of London, London, UK ssadiq@sgul.ac.uk.ORCID 0000-0002-0608-3818
St George's, University of London · GBLondon School of Hygiene & Tropical Medicine · GBSt George’s University Hospitals NHS Foundation Trust · GB

Funding

Department of Health II-LB-0214-20005Medical Research Council G0901608Wellcome Trust 098521Wellcome Trust 102807
6 · The paper itself

Abstract

backgroundMass drug administration (MDA) of 20 mg/kg (maximum 1 g in adults) azithromycin for ocular

objectivesTo determine the effect of MDA for trachoma elimination on

methodsA secondary analysis of CT-negative vulvovaginal swabs from three outpatient antenatal clinics (Honiara, Solomon Islands) from patients recruited either pre-MDA, or 10 months post-MDA in two cross-sectional surveys was carried out. Swabs were tested for

results

conclusionA single round of azithromycin MDA in an island population with high baseline

Indexed as

Drug Resistance, BacterialAdolescentAdultAnti-Bacterial AgentsAzithromycinCluster AnalysisCross-Sectional StudiesDNA, BacterialDNA, RibosomalFemaleGenotypeHumansMass Drug AdministrationMelanesiaMiddle AgedMolecular TypingAnti-Bacterial AgentsAzithromycinDNA, BacterialDNA, RibosomalRNA, Ribosomal, 23Santimicrobial resistanceazithromycindrug resistanceinfectionmass drug administrationmycoplasmaMycoplasma genitaliumtrachoma

Identifiers

PMID30981999
PMCPMC6860407
OpenAlexW2936459952

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.